Introduction
============

Drug and poison information centers (DPICs) have an important role both in supporting rational drug use and collecting data on the prevalence of adverse drug reactions and poisoning. Existence of DPICs improves national drug policy and its standardized indicators in the country. Considering constant growth of medications that are approved for clinical use, there is a need to update the health care professionals in determining dosages, uses and other medication-related issues. On the other hand, physicians and pharmacists have limited the access to the resources of information about drugs and chemicals. For these reasons, DPICs were established with the primary goal of providing accurate and timely drug information to those in urgent need of such information ([@B1]).The first national DPIC in Iran was established in Tehran in early 1995, as a part of food and drug organization of Iran under supervision of the Ministry of Health and Medical Education (MOH) as the national DPIC. Since establishment, it has had an important role for policy making in the dissemination of DPICs in the country. Then, by co-operation of the national DPIC, other DPICs were established countrywide in most of the provinces and the staffs were trained by the national DPIC to learn how to work in a DPIC. At the present, there are 29 active DPICs in Iran working as a network under the supervision of the Medical Universities and MOH ([@B2], [@B3]). Loghman-Hakim DPIC (LHDPIC) is one of them which is established in Loghman Hakim-Hospital Poison Center as a referral center for poisoning, in 2006. The center provides information and advice on medications and poisoning 12 h a day, 7 days a week, from 7 pm to 7 am, but on holidays, the service is 24 h a day. The center has a clinical toxicologist as a director and a toxicologist as a scientific consultant. In the present study, all the recorded queries in the LHDPIC from 2006 to 2008 have been evaluated.

Experimental
============

*Methods*

A special form was used to obtain information regarding every call received by the LHDPIC from March 21, 2006 to March 21, 2008. Collected data included details of the caller, the date and time of the call, the patient›s demographics, nature of enquiry, the chemical or medication which the call focused on and the information resources used to support information provision. Data from this form was extracted and then analyzed statistically using MS-Excel 2007.

Results and Discussion
======================

A total of 9694 calls were received during this period. The center received 2671, 2576 and 4447 inquiries during 2006, 2007 and 2008 years, respectively. Most calls were made by the patients' relatives (49%) and then the patients (45.2%) followed by medical staff (2.86%; [Figure 1](#F1){ref-type="fig"}). All calls were made from different places in Tehran. The gender of the callers showed that 39% were males and 61% were females. The majority of patients (30.35%) were 18-30 years old ([Figure 2](#F2){ref-type="fig"}). Response time was recorded and about 98% of queries were answered within 30 min. All queries were received through telephone and the mode of replay was oral. Most of questions were about drug indications and adverse drug reactions (ADR) (23.9% and 20.14%, respectively) ([Table 1](#T1){ref-type="table"}).
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###### 

The distribution of records according to the type of questions

  **Request Classification**                 **2006**   **2007**   **2008**   **Total (%)**
  ------------------------------------------ ---------- ---------- ---------- ---------------
  **Drug Evaluation and Identification**     529        489        863        1881 (17.64%)
  **Drug Indication**                        789        711        1049       2549 (23.9%)
  **Drug Administration**                    220        497        692        1409 (13.21)
  **Adverse Drug Reaction (ADR)**            695        550        903        2148 (20.14%)
  **Drug Dosage**                            162        127        357        646 (6.06%)
  **Drug Interaction**                       165        168        225        558 (5.23%)
  **Drug in Pregnancy**                      83         116        275        474 (4.44%)
  **Drug in Lactation**                      57         91         98         246 (2.31%)
  **Poisoning and Toxicology**               115        70         152        337 (3.16%)
  **Drug Abuse**                             11         9          17         37 (0.35%)
  **Drug Contraindication and Caution**      49         32         91         172 (1.61%)
  **Pharmacology**                           8          3          12         23 (0.22%)
  **Storage, Stability and Compatibility**   14         12         47         73 (0.68%)
  **Drug Therapy and Comparison**            15         29         68         112 (1.05%)

Regarding compound name, the majority of queries were about antidepressants (12.42%), followed by antimicrobials (12%) and analgesics (11.17%) ([Table 2](#T2){ref-type="table"}).

###### 

The distribution of records according to the classes of drugs

  **Class of Drug**                               **2006**   **2007**   **2008**   **Total (%)**
  ----------------------------------------------- ---------- ---------- ---------- ---------------
  **Antimicrobial**                               317        394        792        1503 (12%)
  **Antiseptic**                                  103        13         30         146 (1.16%)
  **Analgesics and Anesthetic**                   387        379        634        1400 (11.17%)
  **Sedative**                                    321        178        271        770 (6.15%)
  **Anticonvulsant**                              81         80         167        328 (2.62%)
  **Antidepressant**                              400        433        723        1556 (12.42%)
  **Antipsychotic**                               42         80         112        234 (1.87%)
  **Antiparkinsonism**                            23         17         34         74 (0.6%)
  **Digitalis**                                   22         14         45         81 (0.65%)
  **Antihypertensive**                            159        180        319        658 (5.25%)
  **Antiarrythmic**                               38         54         82         174 (1.39%)
  **Antianginal (heart attack)**                  18         68         69         155 (1.24%)
  **Antidiabetic**                                26         57         134        217 (1.73%)
  **Antihyperlipidemic**                          37         37         108        182 (1.45%)
  **Gastrointestinal**                            264        411        570        1245 (9.94%)
  **Dermatologics**                               60         43         100        203 (1.62%)
  **Hair Products**                               23         23         54         100 (0.8%)
  **Cosmetics**                                   13         10         31         54 (0.43%)
  **Diagnostics**                                 14         10         36         60 (0.48%)
  **Aphrodisiactic Drugs**                        338        165        332        835 (6.65%)
  **Hormones**                                    106        92         162        360 (2.87%)
  **Complementary/Alternative Medicine Agents**   29         36         62         127 (1%)
  **Vaccines**                                    17         25         60         102 (0.8%)
  **Otic-Ophthalmic**                             36         27         79         142 (1.13%)
  **Oral products**                               113        18         40         71 (0.57%)
  **Inhalants**                                   44         42         68         154 (1.23%)
  **Nasal products**                              47         21         70         138 (1.1%)
  **Vitamins and Minerals**                       130        116        268        514 (4.1%)
  **Total Parenteral Nutrition(TPN)**             13         18         31         62 (0.5%)
  **Volume Expander/Blood Agents**                56         77         135        268 (2.14%)
  **Immunological Agents**                        13         16         32         61 (0.49%)
  **Herbal Products**                             28         12         47         87 (0.7%)
  **Musculoskeletal Drugs**                       38         65         150        253 (2.02%)
  **Antigout**                                    14         12         36         62 (0.5%)
  **Anti-rheumatoid**                             16         37         59         112 (0.89%)
  **Antidote**                                    11         11         20         42 (0.34%)

The poisoning and toxicology information composed only 3.16% of the received queries. The majority of poisoning was induced by pharmaceuticals (70.04%). Sedative-hypnotics especially benzodiazepines and antidepressants were the major causes of drug poisonings. Other causes of poisoning were chemicals (22%), herbs (3.62%), foods (2.65%) and bites, especially scorpions and bees (1.69%). The questions were answered by the use of information resources such as Micromedex® Healthcare Series (USA, 72%), Iranpharma® (Iran, 24.48%), Drugs in Pregnancy and Lactation (Briggs, 1.90%), Internet search (0.75%), Martindale (the Complete Drug Reference, 0.71%) and others like Goodman and Gilman's the Pharmacological Basis of Therapeutics, National Formulary of Iran (NFI), Harrison's Principles of Internal Medicine, Merck Index, Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Ellenhorn›s Medical Toxicology, Diagnosis and Treatment of Human Poisoning, and INCHEM (0.16%).

Present data show that LHDPIC has provided information, advice and served as a guide for patient management and raised the community awareness regarding drug information. There was an increase in the numbers of calls in 2008 and this indicates the public awareness about the activity of the center. The patients' relatives and females were the most frequent groups who called LHDPIC that is in accordance with previous report of national DPIC of Iran ([@B4]). This indicates more sensitivity and responsibility of patients' relatives about disease status, prescribed drugs, and fate of their patients. The LHDPIC was created to provide unbiased up-to-date drug information to the public for the attainment of high compliance to drug therapy. The calls received from health care professionals at LHDPIC were too little. This finding is different from previous reports of other countries ([@B5]-[@B10]) that most probably return to our different work time. The LHDPIC's work times are at non-official hours and it may be an explanation for few received calls to the center from health care professionals. Another reason may be related to the ignorance of the medical staff about DPIC's services and abilities. Therefore, it is important that the DPIC's services should be adequately communicated to health care providers through various media.

Most of questions were about drug indications and ADR. These findings are similar to previous reports from other countries and also our own country ([@B4]-[@B10]). It may be the result of public accessibility to the Internet and other media, which results in more awareness about drug-induced adverse reactions.The majority of questions were about antidepressants, followed by antimicrobials and analgesics. This finding is in accordance with a previous study in Iran and describes status and pattern of common drug usage at least in Tehran ([@B4]) and is in accordance with official reports about the pattern of drug usage in Iran ([@B11]).Despite the location of the center (inside a referral poison center) and epidemiology of poisoning in Tehran ([@B12]), the poisoning queries received at the center were low. This finding is similar to previous reports from Tehran ([@B4], [@B13]) and seems related to the inadequate general education of the public for calling a DPIC especially in early and pre-hospital phase of poisoning. However, the early phase of poisoning is an opportune time for the treatment of poisoning cases. DPIC has a crucial role for providing information about standard procedures for pre-hospital phase of acute poisoning especially for the lay public. Therefore, more public general education programs for the achievement to this goal are necessary.

The time between calling and answering in LHDPIC showed that most of the calls were answered immediately on the same day. It is attributed to the suitable training and experience of LHDPIC's staff for using drug information resources. Micromedex® is one of the most useful drug information resources in our center. This is related to the comprehensive nature of this drug information resource and the ease of retrieval of relevant information for the drug information process. Other updated textbooks and specialized texts on medicine and pharmacy are still needed to maintain the drug information process. However, the staff at the center recognized that the use of electronic databases as a main resource for the drug information process is more suitable as supported with our previous report.

*Conclusion and recommendation*

The present study showed that the LHDPIC met its objectives of providing drug information for the public but attempts should be made to educate the public about calling DPIC in poisoning cases, especially in the pre-hospital phase. Continuous education of DPIC staff and the establishment of external quality assurance program for DPICs in national levels should be considered.
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